Abatacept injection
Products billed under this code include Orencia.
Payment limit per 10 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Orencia.
Payment limit per 10 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Orencia | E.R. Squibb & Sons, L.L.C. | 00003-2187-13 | 25 | $1,148.425 |
| Orencia | E.R. Squibb & Sons, L.L.C. | 00003-2188-11 | 50 | $2,296.85 |
| Orencia | E.R. Squibb & Sons, L.L.C. | 00003-2188-51 | 50 | $2,296.85 |
| Orencia | E.R. Squibb & Sons, L.L.C. | 00003-2814-11 | 20 | $918.74 |
| Orencia | E.R. Squibb & Sons, L.L.C. | 00003-2818-11 | 35 | $1,607.795 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $45.937 | +$0.078 | 10 MG | Abatacept injection | v1, posted September 17, 2026 |
| 3Q26 | $45.859 | +$1.141 | 10 MG | Abatacept injection | v1, posted September 15, 2026 |
| 2Q26 | $44.718 | −$0.051 | 10 MG | Abatacept injection | v1, posted September 15, 2026 |
| 1Q26 | $44.769 | +$0.66 | 10 MG | Abatacept injection | v1, posted September 15, 2026 |
| 4Q25 | $44.109 | −$0.385 | 10 MG | Abatacept injection | v1, posted September 8, 2026 |
| 3Q25 | $44.494 | +$1.117 | 10 MG | Abatacept injection | v1, posted March 10, 2026 |
| 2Q25 | $43.377 | −$0.42 | 10 MG | Abatacept injection | v1, posted March 10, 2026 |
| 1Q25 | $43.797 | +$0.36 | 10 MG | Abatacept injection | v1, posted December 19, 2025 |
| 4Q24 | $43.437 | −$0.29 | 10 MG | Abatacept injection | v1, posted June 11, 2025 |
| 3Q24 | $43.727 | +$0.887 | 10 MG | Abatacept injection | v1, posted June 11, 2025 |
| 2Q24 | $42.84 | −$0.323 | 10 MG | Abatacept injection | v1, posted March 11, 2025 |
| 1Q24 | $43.163 | +$0.463 | 10 MG | Abatacept injection | v1, posted December 19, 2024 |
| 4Q23 | $42.70 | −$0.571 | 10 MG | Abatacept injection | v1, posted October 10, 2024 |
| 3Q23 | $43.271 | +$0.51 | 10 MG | Abatacept injection | v1, posted June 5, 2024 |
| 2Q23 | $42.761 | −$0.737 | 10 MG | Abatacept injection | v1, posted February 23, 2024 |
| 1Q23 | $43.498 | +$0.252 | 10 MG | Abatacept injection | v1, posted December 6, 2023 |
| 4Q22 | $43.246 | −$0.974 | 10 MG | Abatacept injection | v1, posted June 22, 2023 |
| 3Q22 | $44.22 | +$0.32 | 10 MG | Abatacept injection | v1, posted June 9, 2023 |
| 2Q22 | $43.90 | −$0.622 | 10 MG | Abatacept injection | v1, posted December 14, 2022 |
| 1Q22 | $44.522 | −$0.747 | 10 MG | Abatacept injection | v1, posted June 8, 2022 |
| 4Q21 | $45.269 | −$0.054 | 10 MG | Abatacept injection | v1, posted June 2, 2022 |
| 3Q21 | $45.323 | −$12.508 | 10 MG | Abatacept injection | v1, posted June 2, 2022 |
| 2Q21 | $57.831 | +$0.964 | 10 MG | Abatacept injection | v1, posted March 1, 2022 |
| 1Q21 | $56.867 | – | 10 MG | Abatacept injection | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.